Single-Cell RNA-Sequencing Identifies Immune Biomarkers of Response to Immunotherapy in Patients with High-Risk Smoldering Myeloma
Year: 2021
Type: conference-abstract
Source: Blood
Authors: Romanos Sklavenitis-Pistofidis, Ankit K. Dutta, Sylvia Ujwary, Robert A. Redd, Alexandra Savell, Léa Fléchon, François Aguet, Nicholas Haradhvala, Oksana Zavidij, Mark Bustoros, Sabrin Tahri, Tarek H Mouhieddine, Nang K. Su, Lily Ardente, Shankara Anand, Jacalyn Rosenblatt, Jeffrey A. Zonder, James J. Vredenburgh, Adam Boruchov, Manisha Bhutani, Saad Z. Usmani, Jeffrey V. Matous, Andrew J. Yee, Andrzej Jakubowiak, Claudia E. Paba-Prada, Julia Prescott, Jacob P. Laubach, Salomon Manier, Omar Nadeem, Paul G. Richardson, Ashraf Z. Badros, Lorenzo Trippa, Maria-Victoria Mateos, Gad Getz, Irene M. Ghobrial
Institutions: Broad Institute, Harvard University, Dana-Farber Cancer Institute, Centre National de la Recherche Scientifique, Inserm, Université de Lille, CANTHER - Hétérogénéité, Plasticité et Résistance aux Thérapies des Cancers, Weill Cornell Medicine, Beth Israel Deaconess Medical Center, The Barbara Ann Karmanos Cancer Institute, Levine Cancer Institute, Colorado Blood Cancer Institute, Massachusetts General Hospital, University of Chicago, Centre Hospitalier Universitaire de Lille, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, University of Maryland, Baltimore, Universidad de Salamanca, Instituto de Biología Molecular y Celular del Cáncer de Salamanca
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4200375390